Gholamreza Bahrami

Dr. Gholamreza Bahrami


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2005 in Journal of Chromatography B
Verified
Journal Article
Closed access
GBGholamreza Bahrami
Gholamreza Bahrami
BMBahareh Mohammadi
Bahareh Mohammadi
SMShahla Mirzaeei
Shahla Mirzaeei
AKAmir Kiani
Amir Kiani


13 May 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
Mohammad Bagher MajnooniMohammad Bagher Majnooni
Mohammad Bagher Majnooni
SFSajad Fakhri
Sajad Fakhri
GBGholamreza Bahrami
Gholamreza Bahrami
MNMaryam Naseri
Maryam Naseri
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Javier EcheverríaJavier Echeverría
Javier Echeverría
Since its inception, the coronavirus disease 2019 (COVID-19) pandemic has infected millions of people around the world. Therefore, it is necessary to find effective treatments against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), as it is the viral source of COVID-19. Alkaloids are one of the most widespread plant-derived natural compounds with prominent antiviral effects. Accordingly, these phytochemicals have been promising candidates towards discovering effective treatments for COVID-19. Alkaloids have shown potential anti-SARS-CoV activities via inhibiting pathogenesis-associated targets of the Coronaviridae family that are required for the virus life cycle. In the current study, the chemistry, plant sources, and antiviral effects of alkaloids, as well as their anti-SARS-CoV-2 effect with related mechanisms, are reviewed towards discovering an effective treatment against COVID-19.

22 February 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
Mohammad Bagher MajnooniMohammad Bagher Majnooni
Mohammad Bagher Majnooni
SFSajad Fakhri
Sajad Fakhri
Mustafa GhanadianMustafa Ghanadian
Mustafa Ghanadian
GBGholamreza Bahrami
Gholamreza Bahrami
KMKamran Mansouri
Kamran Mansouri
MMMahdi Mojarrab
Mahdi Mojarrab
Saponins are one of the broadest classes of high-molecular-weight natural compounds, consisting mainly of a non-polar moiety with 27 to 30 carbons and a polar moiety containing sugars attached to the sapogenin structure. Saponins are found in more than 100 plant families as well as found in marine organisms. Saponins have several therapeutic effects, including their administration in the treatment of various cancers. These compounds also reveal noteworthy anti-angiogenesis effects as one of the critical strategies for inhibiting cancer growth and metastasis. In this study, a comprehensive review is performed on electronic databases, including PubMed, Scopus, ScienceDirect, and ProQuest. Accordingly, the structural characteristics of triterpenoid/steroid saponins and their anti-cancer effects were highlighted, focusing on their anti-angiogenic effects and related mechanisms. Consequently, the anti-angiogenic effects of saponins, inhibiting the expression of genes related to vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1-α (HIF-1α) are two main anti-angiogenic mechanisms of triterpenoid and steroidal saponins. The inhibition of inflammatory signaling pathways that stimulate angiogenesis, such as pro-inflammatory cytokines, mitogen-activated protein kinase (MAPKs), and phosphoinositide 3-kinases/protein kinase B (PI3K/Akt), are other anti-angiogenic mechanisms of saponins. Furthermore, the anti-angiogenic and anti-cancer activity of saponins was closely related to the binding site of the sugar moiety, the type and number of their monosaccharide units, as well as the presence of some functional groups in their aglycone structure. Therefore, saponins are suitable candidates for cancer treatment by inhibiting angiogenesis, for which extensive pre-clinical and comprehensive clinical trial studies are recommended.

1 December 2018 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MGMatin Ghaheri
Matin Ghaheri
DKDanial Kahrizi
Danial Kahrizi
GBGholamreza Bahrami
Gholamreza Bahrami
HMHamid-Reza Mohammadi-Motlagh
Hamid-Reza Mohammadi-Motlagh

7 July 2016 in Journal of Evidence-Based Complementary & Alternative Medicine
Verified
Journal Article
Open access
AFAli Fattahi
Ali Fattahi
FNFatemeh Niyazi
Fatemeh Niyazi
BSBehzad Shahbazi
Behzad Shahbazi
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
GBGholamreza Bahrami
Gholamreza Bahrami
Rosa canina fruits have been used traditionally for the treatment of diabetes mellitus and its complications. The aim of current study was to evaluate the in vitro mechanism of action of R canina in managing diabetes mellitus. Cell proliferation and cytotoxicity assay were performed on pancreatic β-cells, βTC6. The protective activity of the extract on streptozotocin-induced death in βTC6 cells was studied. The effect of R canina on the metabolism of glucose in HepG2, a hepatocellular carcinoma cell line, was evaluated. The effect of the extract on glucose diffusion across the dialysis membrane, which is a comfortable model for assessing cellular glucose absorption, was evaluated. The results obtained from current study confirmed that R canina extract can act as a growth factor for pancreatic β-cell line providing a novel mechanism for the observed antidiabetic effect of this natural agent. Further preclinical studies are necessary to evaluate the perfect mechanism of action of R canina in diabetes mellitus.